Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for COUMADIN
- Treatment of Ocular Demodex Infestation With Topical Ivermectin Cream 1%
- Effect of BIA 5-1058 400 mg on Warfarin Pharmacokinetics
- PK Study to Assess Drug-drug Interaction Between Sitravatinib and a Cocktail of Substrates
- A Drug Interaction Study of Danicopan
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
- The Direct Oral Anticoagulation Versus Warfarin After Cardiac Surgery Trial
- Safety and Efficacy of Edoxaban in Thoracoscopic Ablation
- Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study
- Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters
- DOAC Versus VKA After Cardiac Surgery
- Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
- The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis
- Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation
- Efficacy Comparison of Warfarin Versus Rivaroxaban CVT
- Rivaroxaban vs. Warfarin for Post Cardiac Surgery Atrial Fibrillation
- Low INR to Minimize Bleeding With Mechanical Valves Trial
- Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy
- Effect of Pexidartinib on the Way the Body Processes CYP3A4 and CYP2C9 Substrates (Pharmacokinetics)
- Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus
- Start or STop Anticoagulants Randomised Trial (SoSTART)
- Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation
- Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease
- Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus
- Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)
- Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation
- Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation
- Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy
- Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement
- Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
- AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)
- Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.
- Assessment of 2012 Bioequivalence Standards for Warfarin
- The Combined Efficacy of Evicel and Tranexamic Acid on Total Knee Arthroplasty
- Tecarfarin Anti-Coagulation Trial (TACT)
- XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis
- Effects of Epicatechin on Statins for Mitochondrial Dysfunction and Impaired Exercise Capacity
- Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study
- FFP Versus PCC in Intracranial Hemorrhage
- Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service
- The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT
- Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients
- Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis
- Statin Use in Patients With Acute VTE
- Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation
- Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome
- Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
- Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
- Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers
- Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)
- Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque
- Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
- Evaluation of Wound Drainage After Knee or Hip Arthroplasty
- Biomarker-Integrated Approach of Targeted Therapy for Lung Cancer Elimination Plus External Beam Radiation Therapy (BATTLE-XRT)
- CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen
- Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study
- Efficacy of Optison Echo Contrast to Detect Thrombus in Left Atrial Appendage
- Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects
- Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer
- Genetic Response to Warfarin in Healthy Subjects
- Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer
- Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
- Pharmacogenetics of Warfarin Induction and Inhibition
- Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
- The Effects of Ginseng on Cancer-Related Fatigue
- Gemcitabine/Capecitabine Followed by SBRT in Pancreatic Adenocarcinoma
- TPI 287 in Breast Cancer Metastatic to the Brain
- Open Label Use Of RiaStap During Aortic Reconstruction
- Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer
- Human Cytochrome P450 4F Enzymes and Drug Interactions
- Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy
- Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
- Mechanisms Underlying Drug-Diet Interactions
- Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation
- Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT
- Clinical and Economic Implications of Genetic Testing for Warfarin Management
- International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage
- The Effects of Arixtra on Wound Drainage Following Total Joint Arthroplasty
- Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects
- Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
- Comparative Study of Two Brands of Heparin Already on the Market
- Safe, Effective, and More Tolerable 16 Tablets Colon Prep
- Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients
- Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
- Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery
- Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin
- Patent Foramen Ovale in Cryptogenic Stroke Study
- Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation
- Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
- Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
- Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants
- Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)
- Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer
- Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
- 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
- Interaction Between ABT-335, Rosuvastatin and Warfarin
- Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
- Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants
- The Effect of Intraaricular Knee Injections of Hyaluronic Acid (HA) on Bone and Cartilaginous Debris, as a Therapeutic Indicator
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
- BATTLE Program: Sorafenib in Patients With NSCLC
- BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- BATTLE Program: ZD6474 in Previously Treated Subjects With NSCLC
- Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information
- PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care
- LMB-2 to Treat Hairy Cell Leukemia
- CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer
- A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.
- A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery
- Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)
- Odiparcil For The Prevention Of Venous Thromboembolism
- Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
- Defined Green Tea Catechin Extract in Preventing Esophageal Cancer in Patients With Barrett's Esophagus
- Study of Oxaliplatin and Gemcitabine With or Without Bevacizumab to Treat Advanced Non-Small Cell Lung Cancer
- Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer
- Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
- PC-Trial: Patent Foramen Ovale and Cryptogenic Embolism
- Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
- Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters
- Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer
- Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates
- WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation
- Neoadjuvant Chemoradiation With RHUMAB VEGF (Avastin) for Rectal Cancer
- Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
- Low-Dose Alteplase to Treat Blood Clots in Deep Leg Veins
- E-Selectin Nasal Instillation to Prevent Secondary Stroke
- Vitamin K and Bone Turnover in Postmenopausal Women
- Thalidomide-Dexamethasone for Multiple Myeloma
- Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
- Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
- Asymptomatic Carotid Artery Plaque Study (ACAPS)
Clinical trials list
click for details